Analysts expect Hooper Holmes, Inc. (OTCMKTS:HPHW) to report $-0.22 EPS on March, 19.After having $-0.21 EPS previously, Hooper Holmes, Inc.’s analysts see 4.76% EPS growth. The stock decreased 6.00% or $0.03 during the last trading session, reaching $0.47. About shares traded. Hooper Holmes, Inc. (OTCMKTS:HPHW) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.
Intevac, Inc. provides vacuum deposition equipment for various thin-film applications, and digital night-vision technologies and products to the defense industry in the United States, Asia, and Europe. The company has market cap of $136.18 million. It operates through two divisions, Thin-film Equipment and Photonics. It has a 34.72 P/E ratio. The Thin-film Equipment segment designs, makes, markets, and services disk sputtering systems, etch and deposition systems, and disk lubrication systems; and offers upgrades, and spares and consumables, as well as provides process and applications support, customer training, installation, start-up assistance, and post-installation service support services.
Since January 1, 0001, it had 4 insider buys, and 0 selling transactions for $1.58 million activity.
The stock decreased 1.57% or $0.1 during the last trading session, reaching $6.25. About 78,101 shares traded. Intevac, Inc. (IVAC) has risen 164.58% since February 15, 2017 and is uptrending. It has outperformed by 147.88% the S&P500.
Schneider Capital Management Corp holds 0.55% of its portfolio in Intevac, Inc. for 361,686 shares. Pacific Ridge Capital Partners Llc owns 129,330 shares or 0.31% of their US portfolio. Moreover, Essex Investment Management Co Llc has 0.23% invested in the company for 201,247 shares. The New York-based Teton Advisors Inc. has invested 0.17% in the stock. Firsthand Capital Management Inc., a California-based fund reported 15,800 shares.
Hooper Holmes, Inc. provides health and wellness services in the United States. The company has market cap of $12.58 million. The firm offers on-site screenings and flu shots, laboratory testing, risk assessment, and sample collection services to individuals as part of health and wellness programs offered through organizations sponsoring such programs, including corporate and government employers, health plans, hospital systems, health care management companies, wellness companies, brokers and consultants, disease management organizations, reward administrators, third party administrators, clinical research organizations, and academic institutions. It currently has negative earnings. The Company’s screening services include scheduling of individual and group screenings, and organizing health and wellness events; screening event management; provision and fulfillment of supplies at screening events; ScreeningPro tablet technology that streamlines the screening experience for participants eliminating the need to fill out paper forms; performing screenings and blood draws via venipuncture or fingerstick; administration of flu shots, cotinine, and other specialized testing; coordination of lab testing of blood specimens and other fluids; onsite participant wellness coaching; onsite health consultation services; data processing and transmission; analytics to identify critical values of lab tests and notification services; the delivery of other onsite or in-home services; and support of data collection for academic and clinical research organizations.